The first domestic imitation antiepileptic drug clobazam was approved, and Renfu Pharmaceutical responded: it is expected to be launched within this year, and it is expected to enter the medical insurance in 2023


2022-09-23: [Chinese Article Link]  Source: Times Weekly by Wang Dandan From the time that imports are permitted to the first generic drug on the market, the road against epilepsy is finally through the country. On 20 September 2022, the Ichang Pharmacy Company Ltd. (hereinafter referred to as “the Human Pharmacy Industry”) released a message stating that it had recently received approval from the National Drug and Monitoring Service for the issuance of the Certificate of Registration for Drugs for Chlorpa-occupions (hereinafter referred to as the “Certificate”). The issuance of the certificate means that our country is about to have its first chlor-pascadoxin pharmaceutical product, and that the company is also qualified to sell it on the domestic market. In this regard, the director of the Pharmacy for Favour, a correspondent for Times Weekly, said that the follow-up company would place chlorine tablets on the market as soon as possible and was expected to do so in the course of the year. Chlorpa-occupancy is a new type of anti-eclampsia drug, and the Network of Human Favourists has shown that its treatment for children as young as 2 years of age and adults with the Lennox-Gastaut syndrome (hereinafter referred to as LGS) is accurate for epilepsy compared to traditional drugs, with fewer sedatives and related adverse central effects, with fewer drug interactions and better tolerance, has been used as anti-epile treatment in more than 100 countries and has been unanimously endorsed by a wide range of clinical experts. The chlorinated cerebral ailment is a rare form of epileptic encephalitis in LGS, which is prone to early childhood and is manifested as a persistent epilepsy in childhood, with symptoms of epileptic cerebral disease accompanying the patient for life, with a prevalence rate of approximately 2/100.000. Until last June, the National Health Council and the National Drug Control Service issued the Temporary Programme for the Importation of Clinical Emergency Medicines and the Temporary Programme for the Import of Chlorpacasia, which identified 50 hospitals throughout the country as health-care institutions that use chlorbacha, and at least one health-care facility in each province (directly under the Central Government). Source: Imagine. Approved imports “It's like I've been taking pills since I remember, and every weekend of primary school is in a hospital. When I first took debakin, I didn't know it had hormones, so when I was a kid, I was fat, and the whole person was so ashamed. When you get to junior high school, you may have had an epileptic seizure, twice in an ambulance, and fortunately, teachers and classmates don’t look at me differently. “When are these days the 21-year-old Xiaoji said to the Times journalist that he was diagnosed as an epileptic from childhood, that he has been suffering from medication, and that when he is stressed, he is sick, and he never dares to fall in love?” In addition to Xiaoji, Guo is also an epilepsy patient in his 40s this year, and he is not sure what caused the disease, but he has indeed tortured one third of his life. “As a child, being stigmatized on a train is a thief, when there are no relatives to support him, and when he returns home, he has had an epileptic seizure.” Guo-Sang is not sure if he was suffering from the disease because of the incident, but then, as long as he is stressed and nervous, he will have an epileptic seizure. With regard to the use of medicines, Mr. Guo, having heard that the disease is very difficult to cure, does not want to waste money on expensive drugs, and has therefore been eating the “student medicine” distributed by the nearby clinic. Many believe that epilepsy is uncontrollable and incurable, and therefore that the number of visits to epilepsy patients in the country is very low. According to a previous article published by the then Vice-President of the Beijing Institute of Functional Neurosurgery, the rate of visits to epilepsy in the country was less than 40 per cent. According to public sources, epilepsy is the most common chronic neurological disease in the brain, with children and the elderly at two peaks. According to the World Health Organization, there are about 500,000 epilepsy cases worldwide, of which there are about 9 million in China, and 6 million cases continue to occur every year, with 400,000 new cases occurring every year. In contrast to the rare problem of epilepsy, as a life-saving drug for people suffering from the LGS syndrome, the CCP is now approved for anti-epile treatment in more than 100 countries, or even as a first-line drug for paediatric epileptic treatment. However, before this year, the country had neither approved imports of chlor-papazine nor home-grown generics. Patients had to rely on overseas purchases, which, according to the Catalogue of Varieties of Narcotic Drugs and Psychotropic Substances, were addictive and included in the second category of psychopharmaceuticals and were strictly regulated. During the second half of 2021, widespread concern was raised over the problem of chlor-pacasia seizures and the difficulty of purchasing medicines for children suffering from epilepsy, and in December, the National Health Board, in an open response to media concerns, stated that it was organizing a mapping of the sick population and coordinating the organization of centralized applications and imports by the relevant agencies and departments, in accordance with the relevant provisions of the Law on the Administration of Drugs. In June of this year, the National Health Board and the National Institute of Medicine issued the Work Programme for the Temporary Import of Clinical Emergency Medicines and the Work Programme for the Temporary Import of Chlorpacca, which clarified the application process for the temporary import of chlorpacca, the management of the use of medicines, the qualifications and management requirements of prescription physicians, and the responsibilities and responsibilities of the parties concerned. A total of 50 hospitals throughout the country have been identified as health-care facilities using chlor-paccasia, of which six are in Beijing and at least one in other provinces (municipalities directly under the Central Government). Impostorials on the market In addition to allowing imports, we have adopted two routes of “temporary import + imitation” to address the domestic shortage of chlorine papaz. According to the Human Pharmacy Industry, in 2017, in the national catalogue of medicines that are in short supply to encourage research and development, the company paid attention to the use of chlorine. “At that time, we took note of the demand for medicines for this segment of the country’s rare patients, and it is our responsibility, as a company that has developed drugs in the central nervous field for long periods of time, to promote the marketing of the drug. As a follow-up, in collaboration with a wide range of actors, the chlorine-pap film was approved as “fast speed”. In 2018, the Pharmacy Industry approved the approval of the National Institute of Pharmacy, which in the same year began researching literature and craft routes; on 4 March 2022, the Chinese Pharmacy Industry's chlorine-paste film was officially submitted to the market; and in May, the drug received the support of the National Institute of Pharmacy's priority CDE review and entered the “green corridor” on the market. According to the National Drug Monitoring Authority's Government Service Portal, which was released on 19 September, information is pending on the confirmation of pharmaceutical approvals, which was approved on 14 September. With regard to the timing of the marketing of chlorinated tablets, the head of the HFP industry said to the Times Reporter that the exact time was still being determined, but that it had now been approved and should soon be expected to be marketed in the course of the year. In terms of sales prices of most public concern, the current level of imports of chlorine papaz is 50 grains x 20 mg/box with a selling price of approximately 350-550 Yuan yuan/box, and patients have one pill per day, but the amount of medication used will increase according to age and weight increase. In response, the Pharmacy Industry stated to the Times Journalist that the price of the company's chlor-painted tablets needed to be discussed with a wide range of parties, but that the guaranteed availability of medicines would always be paramount in order to effectively address the problem of the use of medicines by patients. It has been reported that the HPV industry has invested approximately 200.000 Yuan in the CCP project and that as the country's first imitation of the CCP, it may have a market monopoly period in the future for some time. The founder and chief attorney of Beijing Hong's law firm, Ma Song, in an earlier interview with the Times Journal journalist, stated that the Patent Dispute Resolution, which was introduced in July 2021, provided for a market monopoly period for the first successful generic challenge, and no further approval was granted for the same type of generics to be placed on the market within 12 months of their first approval. This means that once marketed, or for some time, there will be an exclusive market advantage in the human drug industry. Currently, there is more than one Pharmacy company in the generic industry of chlor-papazine. Last December, according to the National Drug Control Service, eight enterprises have been authorized to develop chlor-papazine in accordance with the relevant regulations. In addition to the human-favourables industry, research and development has been relatively advanced by Synanco Pharmaceuticals and Technology Ltd., which stated last year that the pharmaceutical work on the chlor-Papamic pharmaceutical has been completed and that the progress of research and development has been reported to the Pharmacy Department. In the future, with the introduction into the market of chlor-pap-occupancy medicines, the problem of the use of drugs for epilepsy patients in our country will be substantially improved and breakthroughs will be made. Xiaoji Wen and Shun Guo are aliases


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.




Trending Topics


Trending News

What China Reads


The first domestic imitation antiepileptic drug clobazam was approved, and Renfu Pharmaceutical responded: it is expected to be launched within this year, and it is expected to enter the medical insurance in 2023


2022-09-23: [Article Link]  Source: Times Weekly by Wang Dandan From the time that imports are permitted to the first generic drug on the market, the road against epilepsy is finally through the country. On 20 September 2022, the Ichang Pharmacy Company Ltd. (hereinafter referred to as “the Human Pharmacy Industry”) released a message stating that it had recently received approval from the National Drug and Monitoring Service for the issuance of the Certificate of Registration for Drugs for Chlorpa-occupions (hereinafter referred to as the “Certificate”). The issuance of the certificate means that our country is about to have its first chlor-pascadoxin pharmaceutical product, and that the company is also qualified to sell it on the domestic market. In this regard, the director of the Pharmacy for Favour, a correspondent for Times Weekly, said that the follow-up company would place chlorine tablets on the market as soon as possible and was expected to do so in the course of the year. Chlorpa-occupancy is a new type of anti-eclampsia drug, and the Network of Human Favourists has shown that its treatment for children as young as 2 years of age and adults with the Lennox-Gastaut syndrome (hereinafter referred to as LGS) is accurate for epilepsy compared to traditional drugs, with fewer sedatives and related adverse central effects, with fewer drug interactions and better tolerance, has been used as anti-epile treatment in more than 100 countries and has been unanimously endorsed by a wide range of clinical experts. The chlorinated cerebral ailment is a rare form of epileptic encephalitis in LGS, which is prone to early childhood and is manifested as a persistent epilepsy in childhood, with symptoms of epileptic cerebral disease accompanying the patient for life, with a prevalence rate of approximately 2/100.000. Until last June, the National Health Council and the National Drug Control Service issued the Temporary Programme for the Importation of Clinical Emergency Medicines and the Temporary Programme for the Import of Chlorpacasia, which identified 50 hospitals throughout the country as health-care institutions that use chlorbacha, and at least one health-care facility in each province (directly under the Central Government). Source: Imagine. Approved imports “It's like I've been taking pills since I remember, and every weekend of primary school is in a hospital. When I first took debakin, I didn't know it had hormones, so when I was a kid, I was fat, and the whole person was so ashamed. When you get to junior high school, you may have had an epileptic seizure, twice in an ambulance, and fortunately, teachers and classmates don’t look at me differently. “When are these days the 21-year-old Xiaoji said to the Times journalist that he was diagnosed as an epileptic from childhood, that he has been suffering from medication, and that when he is stressed, he is sick, and he never dares to fall in love?” In addition to Xiaoji, Guo is also an epilepsy patient in his 40s this year, and he is not sure what caused the disease, but he has indeed tortured one third of his life. “As a child, being stigmatized on a train is a thief, when there are no relatives to support him, and when he returns home, he has had an epileptic seizure.” Guo-Sang is not sure if he was suffering from the disease because of the incident, but then, as long as he is stressed and nervous, he will have an epileptic seizure. With regard to the use of medicines, Mr. Guo, having heard that the disease is very difficult to cure, does not want to waste money on expensive drugs, and has therefore been eating the “student medicine” distributed by the nearby clinic. Many believe that epilepsy is uncontrollable and incurable, and therefore that the number of visits to epilepsy patients in the country is very low. According to a previous article published by the then Vice-President of the Beijing Institute of Functional Neurosurgery, the rate of visits to epilepsy in the country was less than 40 per cent. According to public sources, epilepsy is the most common chronic neurological disease in the brain, with children and the elderly at two peaks. According to the World Health Organization, there are about 500,000 epilepsy cases worldwide, of which there are about 9 million in China, and 6 million cases continue to occur every year, with 400,000 new cases occurring every year. In contrast to the rare problem of epilepsy, as a life-saving drug for people suffering from the LGS syndrome, the CCP is now approved for anti-epile treatment in more than 100 countries, or even as a first-line drug for paediatric epileptic treatment. However, before this year, the country had neither approved imports of chlor-papazine nor home-grown generics. Patients had to rely on overseas purchases, which, according to the Catalogue of Varieties of Narcotic Drugs and Psychotropic Substances, were addictive and included in the second category of psychopharmaceuticals and were strictly regulated. During the second half of 2021, widespread concern was raised over the problem of chlor-pacasia seizures and the difficulty of purchasing medicines for children suffering from epilepsy, and in December, the National Health Board, in an open response to media concerns, stated that it was organizing a mapping of the sick population and coordinating the organization of centralized applications and imports by the relevant agencies and departments, in accordance with the relevant provisions of the Law on the Administration of Drugs. In June of this year, the National Health Board and the National Institute of Medicine issued the Work Programme for the Temporary Import of Clinical Emergency Medicines and the Work Programme for the Temporary Import of Chlorpacca, which clarified the application process for the temporary import of chlorpacca, the management of the use of medicines, the qualifications and management requirements of prescription physicians, and the responsibilities and responsibilities of the parties concerned. A total of 50 hospitals throughout the country have been identified as health-care facilities using chlor-paccasia, of which six are in Beijing and at least one in other provinces (municipalities directly under the Central Government). Impostorials on the market In addition to allowing imports, we have adopted two routes of “temporary import + imitation” to address the domestic shortage of chlorine papaz. According to the Human Pharmacy Industry, in 2017, in the national catalogue of medicines that are in short supply to encourage research and development, the company paid attention to the use of chlorine. “At that time, we took note of the demand for medicines for this segment of the country’s rare patients, and it is our responsibility, as a company that has developed drugs in the central nervous field for long periods of time, to promote the marketing of the drug. As a follow-up, in collaboration with a wide range of actors, the chlorine-pap film was approved as “fast speed”. In 2018, the Pharmacy Industry approved the approval of the National Institute of Pharmacy, which in the same year began researching literature and craft routes; on 4 March 2022, the Chinese Pharmacy Industry's chlorine-paste film was officially submitted to the market; and in May, the drug received the support of the National Institute of Pharmacy's priority CDE review and entered the “green corridor” on the market. According to the National Drug Monitoring Authority's Government Service Portal, which was released on 19 September, information is pending on the confirmation of pharmaceutical approvals, which was approved on 14 September. With regard to the timing of the marketing of chlorinated tablets, the head of the HFP industry said to the Times Reporter that the exact time was still being determined, but that it had now been approved and should soon be expected to be marketed in the course of the year. In terms of sales prices of most public concern, the current level of imports of chlorine papaz is 50 grains x 20 mg/box with a selling price of approximately 350-550 Yuan yuan/box, and patients have one pill per day, but the amount of medication used will increase according to age and weight increase. In response, the Pharmacy Industry stated to the Times Journalist that the price of the company's chlor-painted tablets needed to be discussed with a wide range of parties, but that the guaranteed availability of medicines would always be paramount in order to effectively address the problem of the use of medicines by patients. It has been reported that the HPV industry has invested approximately 200.000 Yuan in the CCP project and that as the country's first imitation of the CCP, it may have a market monopoly period in the future for some time. The founder and chief attorney of Beijing Hong's law firm, Ma Song, in an earlier interview with the Times Journal journalist, stated that the Patent Dispute Resolution, which was introduced in July 2021, provided for a market monopoly period for the first successful generic challenge, and no further approval was granted for the same type of generics to be placed on the market within 12 months of their first approval. This means that once marketed, or for some time, there will be an exclusive market advantage in the human drug industry. Currently, there is more than one Pharmacy company in the generic industry of chlor-papazine. Last December, according to the National Drug Control Service, eight enterprises have been authorized to develop chlor-papazine in accordance with the relevant regulations. In addition to the human-favourables industry, research and development has been relatively advanced by Synanco Pharmaceuticals and Technology Ltd., which stated last year that the pharmaceutical work on the chlor-Papamic pharmaceutical has been completed and that the progress of research and development has been reported to the Pharmacy Department. In the future, with the introduction into the market of chlor-pap-occupancy medicines, the problem of the use of drugs for epilepsy patients in our country will be substantially improved and breakthroughs will be made. Xiaoji Wen and Shun Guo are aliases

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.

Recent related articles

Show Advantages / The Bay Area Helps "Going Out" of Traditional Chinese Medicine Treatments

2022-09-24: An intern doctor in Hong Kong is following the teacher for the patient, and the teacher is taking care of the patient. Since the 18th year of the Chinese Communist Party, Chinese medicine has grown steadily and traditional medicine and modern technology have become increasingly integrated,…

After 8 years of retirement, Lan Chengzhang, the former deputy secretary general of the Chengdu Municipal Government, was expelled from the party: the treatment he enjoyed was cancelled according to regulations

2022-09-24: Original title: Eight years of retirement and dismissal of former Deputy Secretary-General of Chengdu: Recently, with the approval of the Cheng City Council, the CAC Supervisory Board conducted a case review of serious breaches of discipline by the former Deputy Secretary-General of the Chengdu…  

Foreign companies take the initiative to come to cooperate with Guangdong's biopharmaceutical industry and embark on the road of innovation

2022-09-23: Guangdong opened up to “new” power to integrate innovation In March 2022, on a normal spring day, Yuanzheng and his colleagues were sitting on a computer screen. Beyond miles, one of the world’s three largest exhibitions of inventions, the Geneva International Inventories Exhibition, was…

[Financial Industry Weekly] China Banking and Insurance Regulatory Commission said that the momentum of real estate financialization and bubbleization has been substantially reversed; Qiu Yong is the secretary of the Party Committee of the Shanghai Stock Exchange; many banks have lowered deposit rates to save space for the downside of LPR; Citi plans to close UK retail banking business ; Private equity tycoon Ge Weidong's two fixed increase and floating losses exceed 200 million yuan; Cai Songsong of Nuo An Fund responds to the rumor of missing contact

2022-09-24: This week (19 September-23 September) the financial sector's information delivery. On the regulatory side, the S.I.E.C. reports a substantial reversal in the trend towards financial bubbles in real estate; central bank data show that the inter-bank currency market in August was paid to a total…

Practice Xi Jinping's Economic Thought Research 丨 Yizhuang explores the new

2022-09-23: Since the Party's eighteenth birthday, General Secretary Xi Jinping has on several occasions given important instructions to work in Beijing, further indicating the direction needed to promote quality development in the capital. In February 2017, the General Secretary Xi Jinping, during his…

Guangdong: Open, Integrate and Innovate to Find a New Track for Medicine-Guangdong-Hong Kong-Macao Greater Bay Area Portal

2022-09-24: Guangdong's New Force In March 2022, on a normal spring day, Yuanzheng and his colleagues were sitting on a computer screen. Beyond miles, one of the world’s three largest exhibitions of inventions, the Geneva International Inventories Exhibition, was “warlike,” with about 800 scientific and…

Beijing accent Beijing rhyme tells grassroots stories "Hutong" set for September 25th

2022-09-24: Since the Party's eighteenth birthday, Secretary-General Xi Jinping has attached great importance to the development of young people's jobs at the village level, emphasizing that “village revitalization is the key to talent” and calling for “the active development of indigenous talent and the…  

Openness, integration and innovation, looking for a new track for medicine丨Guangdong to "new" force

2022-09-23: In March 2022, on a normal spring day, Yuanzheng and his colleagues were sitting in front of the screen. Beyond miles, one of the world’s three largest exhibitions of inventions, the Geneva International Exhibition of Inventors, was “warlike,” with about 800 scientific and technological…

Finance and Economics Knows Early : The National Standing Committee: It is required to pay close attention to the implementation of policies to promote economic stabilization and improvement

2022-09-23: [Domestic finance] The country regularly calls for policies to be taken seriously in order to promote economic stability. Identification of in-depth “one-for-one-one” reforms to facilitate businesses and the population; identification of policies to enhance transport logistics and support…  
Recent related articles

Show Advantages / The Bay Area Helps "Going Out" of Traditional Chinese Medicine Treatments

2022-09-24: An intern doctor in Hong Kong is following the teacher for the patient, and the teacher is taking care of the patient. Since the 18th year of the Chinese Communist Party, Chinese medicine has grown steadily and traditional medicine and modern technology have become increasingly integrated,…

After 8 years of retirement, Lan Chengzhang, the former deputy secretary general of the Chengdu Municipal Government, was expelled from the party: the treatment he enjoyed was cancelled according to regulations

2022-09-24: Original title: Eight years of retirement and dismissal of former Deputy Secretary-General of Chengdu: Recently, with the approval of the Cheng City Council, the CAC Supervisory Board conducted a case review of serious breaches of discipline by the former Deputy Secretary-General of the Chengdu…  

Foreign companies take the initiative to come to cooperate with Guangdong's biopharmaceutical industry and embark on the road of innovation

2022-09-23: Guangdong opened up to “new” power to integrate innovation In March 2022, on a normal spring day, Yuanzheng and his colleagues were sitting on a computer screen. Beyond miles, one of the world’s three largest exhibitions of inventions, the Geneva International Inventories Exhibition, was…

[Financial Industry Weekly] China Banking and Insurance Regulatory Commission said that the momentum of real estate financialization and bubbleization has been substantially reversed; Qiu Yong is the secretary of the Party Committee of the Shanghai Stock Exchange; many banks have lowered deposit rates to save space for the downside of LPR; Citi plans to close UK retail banking business ; Private equity tycoon Ge Weidong's two fixed increase and floating losses exceed 200 million yuan; Cai Songsong of Nuo An Fund responds to the rumor of missing contact

2022-09-24: This week (19 September-23 September) the financial sector's information delivery. On the regulatory side, the S.I.E.C. reports a substantial reversal in the trend towards financial bubbles in real estate; central bank data show that the inter-bank currency market in August was paid to a total…

Practice Xi Jinping's Economic Thought Research 丨 Yizhuang explores the new

2022-09-23: Since the Party's eighteenth birthday, General Secretary Xi Jinping has on several occasions given important instructions to work in Beijing, further indicating the direction needed to promote quality development in the capital. In February 2017, the General Secretary Xi Jinping, during his…

Guangdong: Open, Integrate and Innovate to Find a New Track for Medicine-Guangdong-Hong Kong-Macao Greater Bay Area Portal

2022-09-24: Guangdong's New Force In March 2022, on a normal spring day, Yuanzheng and his colleagues were sitting on a computer screen. Beyond miles, one of the world’s three largest exhibitions of inventions, the Geneva International Inventories Exhibition, was “warlike,” with about 800 scientific and…

Beijing accent Beijing rhyme tells grassroots stories "Hutong" set for September 25th

2022-09-24: Since the Party's eighteenth birthday, Secretary-General Xi Jinping has attached great importance to the development of young people's jobs at the village level, emphasizing that “village revitalization is the key to talent” and calling for “the active development of indigenous talent and the…  

Openness, integration and innovation, looking for a new track for medicine丨Guangdong to "new" force

2022-09-23: In March 2022, on a normal spring day, Yuanzheng and his colleagues were sitting in front of the screen. Beyond miles, one of the world’s three largest exhibitions of inventions, the Geneva International Exhibition of Inventors, was “warlike,” with about 800 scientific and technological…

Finance and Economics Knows Early : The National Standing Committee: It is required to pay close attention to the implementation of policies to promote economic stabilization and improvement

2022-09-23: [Domestic finance] The country regularly calls for policies to be taken seriously in order to promote economic stability. Identification of in-depth “one-for-one-one” reforms to facilitate businesses and the population; identification of policies to enhance transport logistics and support…